Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB).
Richardson TR. et al, (2023), BMC infectious diseases, 23
Evaluation of the molecular bacterial load assay for detecting viable Mycobacterium tuberculosis in cerebrospinal fluid before and during tuberculous meningitis treatment.
Hai HT. et al, (2021), Tuberculosis (Edinburgh, Scotland), 128
Most-Probable-Number-Based Minimum Duration of Killing Assay for Determining the Spectrum of Rifampicin Susceptibility in Clinical Mycobacterium tuberculosis Isolates.
Vijay S. et al, (2021), Antimicrobial agents and chemotherapy, 65
Sources of Multidrug Resistance in Patients With Previous Isoniazid-Resistant Tuberculosis Identified Using Whole Genome Sequencing: A Longitudinal Cohort Study
Srinivasan V. et al, (2020), Clinical Infectious Diseases, 71, e532 - e539
Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study
Donovan J. et al, (2020), The Lancet Infectious Diseases, 20, 299 - 307
Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study.
Van LH. et al, (2020), BMC infectious diseases, 20
Development of ligand‐coated beads to measure macrophage antimicrobial activities
Tram TTB. et al, (2019), Biology of the Cell, 111, 262 - 270
Do Intracerebral Cytokine Responses Explain the Harmful Effects of Dexamethasone in Human Immunodeficiency Virus–associated Cryptococcal Meningitis?
Beardsley J. et al, (2019), Clinical Infectious Diseases, 68, 1494 - 1501
Pretreatment Cerebrospinal Fluid Bacterial Load Correlates With Inflammatory Response and Predicts Neurological Events During Tuberculous Meningitis Treatment
Thuong NTT. et al, (2019), The Journal of Infectious Diseases, 219, 986 - 995
Increasing women's leadership in science in Ho Chi Minh City.
Hoa NT. et al, (2019), Lancet (London, England), 393, 523 - 524
Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis
Thai PVK. et al, (2018), BMC Infectious Diseases, 18
Improving the microbiological diagnosis of tuberculous meningitis: A prospective, international, multicentre comparison of conventional and modified Ziehl–Neelsen stain, GeneXpert, and culture of cerebrospinal fluid
Heemskerk AD. et al, (2018), Journal of Infection, 77, 509 - 515
Modeling tuberculosis dynamics with the presence of hyper-susceptible individuals for Ho Chi Minh City from 1996 to 2015
Vinh DN. et al, (2018), BMC Infectious Diseases, 18
Virulence of Mycobacterium tuberculosis Clinical Isolates Is Associated With Sputum Pre-treatment Bacterial Load, Lineage, Survival in Macrophages, and Cytokine Response
Tram TTB. et al, (2018), Frontiers in Cellular and Infection Microbiology, 8
Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): Study protocol for a randomised controlled trial
Donovan J. et al, (2018), Wellcome Open Research, 3, 31 - 31
Frequent transmission of the Mycobacterium tuberculosis Beijing lineage and positive selection for the EsxW Beijing variant in Vietnam
Holt KE. et al, (2018), Nature Genetics, 50, 849 - 856
Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): Study protocol for a randomised controlled trial
Donovan J. et al, (2018), Wellcome Open Research, 3, 31 - 31
Adjunctive dexamethasone for the treatment of HIV-uninfected adults with tuberculous meningitis stratified by Leukotriene A4 hydrolase genotype (LAST ACT): Study protocol for a randomised double blind placebo controlled non-inferiority trial
Donovan J. et al, (2018), Wellcome Open Research, 3, 32 - 32
A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults
Mai NTH. et al, (2018), eLife, 7
Prognostic Models for 9-Month Mortality in Tuberculous Meningitis
Thao LTP. et al, (2018), Clinical Infectious Diseases, 66, 523 - 532